MedTrace Logo

Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System

NCT02189551 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2018-08-15

No results posted yet for this study

Summary

The objective of the study is to compare a new medical devices with an established medical device for lower limb rehabilitation regarding training outcome and patient comfort / patient satisfaction (primary objective) and treatment effect (exploratory objective).

Primary study endpoints will be a significantly higher rated patient comfort and or patient satisfaction using the new versions, compared with the established Lokomat. Furthermore, muscle activity and kinematic movement patterns will be expected to show more involved muscle groups and a walking pattern involving more degrees of freedom during use of the new version compared with the established Lokomat.

Exploratory endpoints will be a significantly stronger involvement of muscles needed for balance, more physiological walking patterns and more change on the lateral positioning of the feet due to training with the new version, compared with the established Lokomat.

Conditions

  • Post Stroke Gait Training

Interventions

BEHAVIORAL

Gait training with Lokomat Pro

BEHAVIORAL

Gait training with Lokomat Pro FreeD

Sponsors & Collaborators

  • Swiss Commission for Technology and Innovation

    collaborator OTHER

  • Swiss Federal Institute of Technology

    collaborator OTHER

  • Hocoma AG

    collaborator UNKNOWN

  • University of Zurich

    collaborator OTHER

  • Cereneo AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02189551 on ClinicalTrials.gov